SK hynix Announces FY25 Financial Results… Posts Record-High Results and Delivers Highest Shareholder Returns
Achieves all-time high annual and quarterly results, driven by AI memory competitiveness and high value-added products including HBM Reports FY2025 revenue of 97.1467 trillion won, operating profit of 47.2063 trillion won, net profit of 42.9479...
Digital Edge Announces Landmark US$4.5 Billion Investment to Build Indonesia's Largest 500MW AI-Ready Hyperscale Campus
SINGAPORE, Jan. 28, 2026 /PRNewswire/ -- Digital Edge today announced a US$4.5 billion investment to build CGK Campus, one of Indonesia's largest AI-ready hyperscale data center campuses, in the GIIC Industrial Estate in Bekasi. The 500MW CGK Campus...
AllsWell Marks Consecutive Appearances at CES: From Managed Brand PR to GEO, Advancing Brand Growth in the Generative Search Era
At CES 2026, AllsWell Announces Strategic Partnership with LEAP GEO to Help Brands Move from Exposure to AI Citations and Recommendations LAS VEGAS, Jan. 27, 2026 /PRNewswire/ -- Global brand communications and public relations consultancy AllsWell...
Antigravity Updates A1 with Virtual Flight Simulator and Announces 15% Off US Sale
The world's first 8K 360 drone expands US retail availability to Amazon following breakout success at CES. LOS ANGELES, Jan. 27, 2026 /PRNewswire/ -- Antigravity will announce a major feature update for the Antigravity A1, introducing a built-in...
Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease
Nine-month findings show mean improvement in Composite Unified Huntington's Disease Rating Scale from baseline of +0.64 points, compared to natural history expected worsening of cUHDRS in symptomatic patients of -0.73 points over nine months, based...
Nexdata Announces Completion and Full Operation of Its World-Class Embodied AI Data Collection Factory
SINGAPORE, Jan. 27, 2026 /PRNewswire/ -- As embodied AI rapidly evolves from foundation models and software-based agents toward real-world intelligent robots, the industry is facing a critical bottleneck: the large-scale availability of...
Nuance Pharma Announces Acceptance for Review of the New Drug Application for Ohtuvayre® (ensifentrine) by the National Medical Products Administration of China for the maintenance treatment of chronic obstructive pulmonary disease
SHANGHAI, Jan. 27, 2026 /PRNewswire/ -- Nuance Pharma ("Nuance") today announced that the National Medical Products Administration (NMPA) of China has officially accepted for review the New Drug Application (NDA) for Ohtuvayre ® (ensifentrine) for...
Alphamab Oncology Announces the Results of a Phase III Clinical Study of Anbenitamab (KN026) were Published in Annals of Oncology
SUZHOU, China, Jan. 27, 2026 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) announced that the results from a phase III clinical study for the treatment of HER2-positive gastric or gastroesophageal junction cancer (GC/GEJ) of anbenitamab...
Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for Relapsed or Refractory Multiple Myeloma
SAN FRANCISCO and SUZHOU, China, Jan. 27, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of...
TIAN RUIXIANG Holdings Ltd. Announces Receipt of Nasdaq Delisting Notification Regarding Minimum Bid Price Deficiency
BEIJING, Jan. 27, 2026 /PRNewswire/ -- TIAN RUIXIANG Holdings Ltd. (Nasdaq: TIRX) (the "Company" or "TRX") today announced that it had received a written notification (the "Notice") from the Listing Qualifications (the "Staff") of The Nasdaq Stock...